Search

Free Symposia: Unlocking High-Throughput Biology and Drug Discovery…

…a pair-wise combinatorial way and just ask the question, can these two antibodies bind the target at the same time, and form a sandwich complex or does the binding of…

…at that point it does the referencing, the blank subtraction and the kinetic fit all as one automated process. Depending on your computer and how complicated the assay is, that…

…throughput via combinatorial approaches DNA-tagged fragments, compounds, or TPDs are arrayed as individual locations on a 384-spot array by oligonucleotide hybridization. Once binding kinetics against target and/or off-target are complete,…

…communities to have this capability,” he added. Longer term, Takulapalli said SPOC aims to make its chips compatible with SPR instruments from a variety of companies. He said a core…

…is developing the next generation of label-free biosensors for drug discovery and life science research. For further information, please contact: Josh Eckman CEO P: 844-642-7635 x700 Carterra, Inc. info@carterra-bio.com www.carterra-bio.com…

…are 5000 diseases out there without a cure. A lot of them are in such small numbers that big pharmaceutical companies, even small pharmaceutical companies don’t have the resource, or…

…founded in 2001 and based in San Francisco and San Diego, CA, invests in innovative commercial stage life science, medical technology and healthcare companies. For more information please visit www.telegraphhillpartners.com….

…voltage-gated ion channels and P-type ATPases. It kinda gives you a comparison of the genes that encode those proteins in tetrahymena compared to what’s encoded in human cells. And for…

.